Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-19-004240
Filing Date
2019-03-29
Accepted
2019-03-29 16:20:54
Documents
50
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 765180
2 logo.jpg GRAPHIC 40261
3 ex10-23.htm EX-10.23 1138
4 ex10-23_001.jpg GRAPHIC 90041
5 ex10-24.htm EX-10.24 1133
6 ex10-24_001.jpg GRAPHIC 138588
7 ex10-25.htm EX-10.25 1234
8 ex10-25_001.jpg GRAPHIC 103429
9 ex10-26.htm EX-10.26 994
10 ex10-26_001.jpg GRAPHIC 74697
11 ex31-1.htm EX-31.1 17503
12 ex31-2.htm EX-31.2 17557
13 ex32-1.htm EX-32.1 8508
  Complete submission text file 0001493152-19-004240.txt   2627283

Data Files

Seq Description Document Type Size
14 XBRL INSTANCE FILE vapa-20181231.xml EX-101.INS 143366
15 XBRL SCHEMA FILE vapa-20181231.xsd EX-101.SCH 17654
16 XBRL CALCULATION FILE vapa-20181231_cal.xml EX-101.CAL 27126
17 XBRL DEFINITION FILE vapa-20181231_def.xml EX-101.DEF 82013
18 XBRL LABEL FILE vapa-20181231_lab.xml EX-101.LAB 154601
19 XBRL PRESENTATION FILE vapa-20181231_pre.xml EX-101.PRE 130004
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
VapAria Corp (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55470 | Film No.: 19716709
SIC: 2834 Pharmaceutical Preparations